Viewing Study NCT06402760



Ignite Creation Date: 2024-05-11 @ 8:31 AM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06402760
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-07
First Post: 2024-04-09

Brief Title: Comprehensive Intervention of Diabetes and Psoriasis Comorbidity Prevention and Control
Sponsor: Shanghai Yueyang Integrated Medicine Hospital
Organization: Shanghai Yueyang Integrated Medicine Hospital

Study Overview

Official Title: A Cohort Study on Comprehensive Intervention of Diabetes and Psoriasis Comorbidity Prevention and Control Using Traditional Chinese Medicine of Blood-activating and Stasis-dissolving Method
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: We will recruit 300 patients with psoriasis from Yueyang Hospital of Integrative Medicine Shanghai University of Traditional Chinese Medicine who will not be currently diagnosed with diabetes but will have been identified as high-risk individuals based on the developed risk assessment model Based on doctors treatment opinions and patient preferences participants will be divided into two groups in a 11 ratio a Western medicine group and a TCM comprehensive treatment group

Patients in the Western medicine group will receive treatment according to guidelines Patients in the TCM comprehensive treatment group will be treated according to the guidelines and will additionally receive Taodan granules to be taken daily during the treatment period after brewing the granules with lukewarm water in the morning and evening and fish oil 1g taken orally twice daily

Patients in the TCM comprehensive treatment group will be required to complete at least 150 minutes of moderate-intensity aerobic exercise per week under the supervision of a physician The patients will be treated for 16 weeks and followed up for 24 weeks to see if the treatment prevents the development of diabetes or insulin resistance
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None